#begin document (wsj_1938.en); part 000
wsj_1938.en	0	0	Ciba-Geigy	(1|(4
wsj_1938.en	0	1	Ltd.	4)
wsj_1938.en	0	2	and	-
wsj_1938.en	0	3	Chiron	(5
wsj_1938.en	0	4	Corp.	1)|5)
wsj_1938.en	0	5	said	-
wsj_1938.en	0	6	they	(1)
wsj_1938.en	0	7	extended	-
wsj_1938.en	0	8	their	(1)|(2
wsj_1938.en	0	9	offer	-
wsj_1938.en	0	10	for	-
wsj_1938.en	0	11	Connaught	(3
wsj_1938.en	0	12	BioSciences	-
wsj_1938.en	0	13	Inc.	3)
wsj_1938.en	0	14	,	-
wsj_1938.en	0	15	valued	-
wsj_1938.en	0	16	at	-
wsj_1938.en	0	17	866	-
wsj_1938.en	0	18	million	-
wsj_1938.en	0	19	Canadian	-
wsj_1938.en	0	20	dollars	-
wsj_1938.en	0	21	-LRB-	-
wsj_1938.en	0	22	US$	-
wsj_1938.en	0	23	736	-
wsj_1938.en	0	24	million	-
wsj_1938.en	0	25	-RRB-	2)
wsj_1938.en	0	26	to	-
wsj_1938.en	0	27	Oct.	-
wsj_1938.en	0	28	27	-
wsj_1938.en	0	29	.	-

wsj_1938.en	0	0	The	(1
wsj_1938.en	0	1	companies	1)
wsj_1938.en	0	2	earlier	-
wsj_1938.en	0	3	said	-
wsj_1938.en	0	4	they	(1)
wsj_1938.en	0	5	did	-
wsj_1938.en	0	6	n't	-
wsj_1938.en	0	7	want	-
wsj_1938.en	0	8	to	-
wsj_1938.en	0	9	raise	-
wsj_1938.en	0	10	their	(1)|(2
wsj_1938.en	0	11	offer	2)
wsj_1938.en	0	12	to	-
wsj_1938.en	0	13	match	-
wsj_1938.en	0	14	a	-
wsj_1938.en	0	15	rival	-
wsj_1938.en	0	16	bid	-
wsj_1938.en	0	17	by	-
wsj_1938.en	0	18	Institut	(6
wsj_1938.en	0	19	Merieux	-
wsj_1938.en	0	20	S.A.	6)
wsj_1938.en	0	21	of	-
wsj_1938.en	0	22	C$	-
wsj_1938.en	0	23	37	-
wsj_1938.en	0	24	a	-
wsj_1938.en	0	25	share	-
wsj_1938.en	0	26	,	-
wsj_1938.en	0	27	or	-
wsj_1938.en	0	28	C$	-
wsj_1938.en	0	29	942	-
wsj_1938.en	0	30	million	-
wsj_1938.en	0	31	.	-

wsj_1938.en	0	0	But	-
wsj_1938.en	0	1	they	(1)
wsj_1938.en	0	2	said	-
wsj_1938.en	0	3	the	(2
wsj_1938.en	0	4	C$	-
wsj_1938.en	0	5	30-a-share	-
wsj_1938.en	0	6	bid	-
wsj_1938.en	0	7	,	2)
wsj_1938.en	0	8	which	(2)
wsj_1938.en	0	9	was	-
wsj_1938.en	0	10	due	-
wsj_1938.en	0	11	to	-
wsj_1938.en	0	12	expire	-
wsj_1938.en	0	13	Monday	-
wsj_1938.en	0	14	,	-
wsj_1938.en	0	15	may	-
wsj_1938.en	0	16	still	-
wsj_1938.en	0	17	be	-
wsj_1938.en	0	18	extended	-
wsj_1938.en	0	19	or	-
wsj_1938.en	0	20	varied	-
wsj_1938.en	0	21	.	-

wsj_1938.en	0	0	Merieux	(6)
wsj_1938.en	0	1	,	-
wsj_1938.en	0	2	a	(6
wsj_1938.en	0	3	vaccine	-
wsj_1938.en	0	4	manufacturer	6)
wsj_1938.en	0	5	based	-
wsj_1938.en	0	6	in	-
wsj_1938.en	0	7	Lyon	-
wsj_1938.en	0	8	,	-
wsj_1938.en	0	9	France	(7)
wsj_1938.en	0	10	,	-
wsj_1938.en	0	11	is	-
wsj_1938.en	0	12	51%-held	-
wsj_1938.en	0	13	by	-
wsj_1938.en	0	14	French	-
wsj_1938.en	0	15	state-owned	(7)
wsj_1938.en	0	16	Rhone-Poulenc	-
wsj_1938.en	0	17	S.A	-
wsj_1938.en	0	18	.	-

wsj_1938.en	0	0	Ciba-Geigy	(4)
wsj_1938.en	0	1	is	-
wsj_1938.en	0	2	a	(8
wsj_1938.en	0	3	major	-
wsj_1938.en	0	4	pharmaceutical	-
wsj_1938.en	0	5	concern	8)
wsj_1938.en	0	6	based	-
wsj_1938.en	0	7	in	-
wsj_1938.en	0	8	Basel	-
wsj_1938.en	0	9	,	-
wsj_1938.en	0	10	Switzerland	-
wsj_1938.en	0	11	.	-

wsj_1938.en	0	0	Chiron	(5)
wsj_1938.en	0	1	,	-
wsj_1938.en	0	2	another	(5
wsj_1938.en	0	3	pharmaceutical	-
wsj_1938.en	0	4	concern	5)
wsj_1938.en	0	5	,	-
wsj_1938.en	0	6	is	-
wsj_1938.en	0	7	based	-
wsj_1938.en	0	8	in	-
wsj_1938.en	0	9	Emeryville	-
wsj_1938.en	0	10	,	-
wsj_1938.en	0	11	Calif	-
wsj_1938.en	0	12	.	-

wsj_1938.en	0	0	Connaught	(3)
wsj_1938.en	0	1	is	-
wsj_1938.en	0	2	a	-
wsj_1938.en	0	3	biotechnology	-
wsj_1938.en	0	4	research	-
wsj_1938.en	0	5	and	-
wsj_1938.en	0	6	vaccine	-
wsj_1938.en	0	7	manufacturing	-
wsj_1938.en	0	8	concern	-
wsj_1938.en	0	9	.	-

wsj_1938.en	0	0	Institut	(6
wsj_1938.en	0	1	Merieux	-
wsj_1938.en	0	2	's	6)
wsj_1938.en	0	3	bid	-
wsj_1938.en	0	4	for	-
wsj_1938.en	0	5	Toronto-based	(3
wsj_1938.en	0	6	Connaught	3)
wsj_1938.en	0	7	has	-
wsj_1938.en	0	8	run	-
wsj_1938.en	0	9	into	-
wsj_1938.en	0	10	problems	-
wsj_1938.en	0	11	with	-
wsj_1938.en	0	12	the	(9
wsj_1938.en	0	13	Canadian	-
wsj_1938.en	0	14	government	9)
wsj_1938.en	0	15	,	-
wsj_1938.en	0	16	which	(9)|(10
wsj_1938.en	0	17	told	-
wsj_1938.en	0	18	Merieux	(6)
wsj_1938.en	0	19	last	-
wsj_1938.en	0	20	week	-
wsj_1938.en	0	21	that	-
wsj_1938.en	0	22	it	(9)
wsj_1938.en	0	23	was	-
wsj_1938.en	0	24	n't	-
wsj_1938.en	0	25	convinced	-
wsj_1938.en	0	26	that	-
wsj_1938.en	0	27	the	-
wsj_1938.en	0	28	proposed	-
wsj_1938.en	0	29	acquisition	-
wsj_1938.en	0	30	would	-
wsj_1938.en	0	31	be	-
wsj_1938.en	0	32	of	-
wsj_1938.en	0	33	``	-
wsj_1938.en	0	34	net	-
wsj_1938.en	0	35	benefit	-
wsj_1938.en	0	36	''	-
wsj_1938.en	0	37	to	-
wsj_1938.en	0	38	Canada	10)
wsj_1938.en	0	39	.	-

wsj_1938.en	0	0	Merieux	(6)|(12
wsj_1938.en	0	1	officials	12)
wsj_1938.en	0	2	are	-
wsj_1938.en	0	3	expected	-
wsj_1938.en	0	4	to	-
wsj_1938.en	0	5	meet	-
wsj_1938.en	0	6	with	-
wsj_1938.en	0	7	federal	(11
wsj_1938.en	0	8	officials	11)
wsj_1938.en	0	9	in	-
wsj_1938.en	0	10	Ottawa	-
wsj_1938.en	0	11	today	-
wsj_1938.en	0	12	to	-
wsj_1938.en	0	13	discuss	-
wsj_1938.en	0	14	the	(10
wsj_1938.en	0	15	decision	10)
wsj_1938.en	0	16	.	-

#end document 